{"id":"https://openalex.org/W3094053938","doi":"https://doi.org/10.1186/s12931-020-01541-7","title":"DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma","display_name":"DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma","alternate_titles":[],"publication_year":2020,"publication_date":"2020-10-21","ids":{"openalex":"https://openalex.org/W3094053938","doi":"https://doi.org/10.1186/s12931-020-01541-7","mag":"3094053938","pmid":"https://pubmed.ncbi.nlm.nih.gov/33087119","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7576983"},"language":"en","primary_location":{"id":"doi:10.1186/s12931-020-01541-7","doi":"https://doi.org/10.1186/s12931-020-01541-7","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12931-020-01541-7","pdf_url":"https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-020-01541-7","source":{"id":"https://openalex.org/S186153782","display_name":"Respiratory Research","issn_l":"1465-9921","issn":["1465-9921","1465-993X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3094053938"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-020-01541-7","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022389916","display_name":"Andrew N Menzies-Gow","orcid":"https://orcid.org/0000-0001-9707-4986","observed_orcids":["https://orcid.org/0000-0001-9707-4986"]},"institutions":[{"id":"https://openalex.org/I4210096640","display_name":"Royal Brompton Hospital","ror":"https://ror.org/00cv4n034","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800036501","https://openalex.org/I4210096640"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Andrew Menzies-Gow","raw_affiliation_strings":["Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK. A.Menzies-Gow@rbht.nhs.uk","Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK. A.Menzies-Gow@rbht.nhs.uk","institution_ids":["https://openalex.org/I4210096640"]},{"raw_affiliation_string":"Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK","institution_ids":["https://openalex.org/I4210096640"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035827499","display_name":"Sandhia S. Ponnarambil","orcid":"https://orcid.org/0009-0008-8310-6041","observed_orcids":["https://orcid.org/0009-0008-8310-6041"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sandhia Ponnarambil","raw_affiliation_strings":["Late Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John Downie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Downie","raw_affiliation_strings":["Amgen, Thousand Oaks, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110767855","display_name":"Karin Bowen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karin Bowen","raw_affiliation_strings":["Biometrics, Late Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biometrics, Late Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017351500","display_name":"\u00c5sa Hellqvist","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"\u00c5sa Hellqvist","raw_affiliation_strings":["Biometrics, Late Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biometrics, Late Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068913631","display_name":"Gene Colice","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gene Colice","raw_affiliation_strings":["Late Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5022389916"],"corresponding_institution_ids":["https://openalex.org/I4210096640"],"apc_list":{"value":2790,"currency":"USD","value_usd":2790},"apc_paid":{"value":2790,"currency":"USD","value_usd":2790},"fwci":4.6184,"has_fulltext":true,"cited_by_count":76,"citation_normalized_percentile":{"value":0.96369396,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"21","issue":"1","first_page":"279","last_page":"279"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10877","display_name":"Allergic Rhinitis and Sensitization","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/severe-uncontrolled-asthma","display_name":"severe uncontrolled asthma","score":0.8230000138282776},{"id":"https://openalex.org/keywords/thymic-stromal-lymphopoietin","display_name":"thymic stromal lymphopoietin","score":0.9670000076293945},{"id":"https://openalex.org/keywords/long-term-safety-and-tolerability","display_name":"long-term safety and tolerability","score":0.8510000109672546},{"id":"https://openalex.org/keywords/asthma-exacerbations","display_name":"asthma exacerbations","score":0.800000011920929},{"id":"https://openalex.org/keywords/monoclonal-antibody-therapy","display_name":"monoclonal antibody therapy","score":0.7369999885559082},{"id":"https://openalex.org/keywords/long-term-extension-study","display_name":"long-term extension study","score":0.6399999856948853},{"id":"https://openalex.org/keywords/controller-medications","display_name":"controller medications","score":0.4740000069141388},{"id":"https://openalex.org/keywords/inhaled-corticosteroids","display_name":"inhaled corticosteroids","score":0.7319999933242798}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8686217069625854},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8242307901382446},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7140056490898132},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.654144287109375},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.5723826885223389},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5062384009361267},{"id":"https://openalex.org/C2778070265","wikidata":"https://www.wikidata.org/wiki/Q18048067","display_name":"Thymic stromal lymphopoietin","level":3,"score":0.49820399284362793},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4689065217971802},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.42173415422439575},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38406264781951904},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.34641844034194946},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.07476747035980225},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000094632","descriptor_name":"Thymic Stromal Lymphopoietin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000280","descriptor_name":"Administration, Inhalation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018927","descriptor_name":"Anti-Asthmatic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018927","descriptor_name":"Anti-Asthmatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018927","descriptor_name":"Anti-Asthmatic Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/s12931-020-01541-7","doi":"https://doi.org/10.1186/s12931-020-01541-7","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12931-020-01541-7","pdf_url":"https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-020-01541-7","source":{"id":"https://openalex.org/S186153782","display_name":"Respiratory Research","issn_l":"1465-9921","issn":["1465-9921","1465-993X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory Research","raw_type":"journal-article"},{"id":"pmid:33087119","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33087119","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory research","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:pubmedcentral.nih.gov:7576983","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7576983/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respir Res","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:666023d7ad3246cfacc77010fc431de5","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/666023d7ad3246cfacc77010fc431de5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Respiratory Research, Vol 21, Iss 1, Pp 1-10 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12931-020-01541-7","doi":"https://doi.org/10.1186/s12931-020-01541-7","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12931-020-01541-7","pdf_url":"https://respiratory-research.biomedcentral.com/track/pdf/10.1186/s12931-020-01541-7","source":{"id":"https://openalex.org/S186153782","display_name":"Respiratory Research","issn_l":"1465-9921","issn":["1465-9921","1465-993X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3094053938.pdf","grobid_xml":"https://content.openalex.org/works/W3094053938.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W387031605","https://openalex.org/W1975438745","https://openalex.org/W2011998167","https://openalex.org/W2041651163","https://openalex.org/W2042181177","https://openalex.org/W2055172715","https://openalex.org/W2055220989","https://openalex.org/W2057490898","https://openalex.org/W2077917566","https://openalex.org/W2105680170","https://openalex.org/W2110052844","https://openalex.org/W2131268464","https://openalex.org/W2137379305","https://openalex.org/W2137697937","https://openalex.org/W2151041131","https://openalex.org/W2156916462","https://openalex.org/W2162803006","https://openalex.org/W2167829087","https://openalex.org/W2170948066","https://openalex.org/W2515998798","https://openalex.org/W2752584372","https://openalex.org/W2767294221","https://openalex.org/W2896299453","https://openalex.org/W2899608945","https://openalex.org/W2903790709","https://openalex.org/W2951877381","https://openalex.org/W2954332387","https://openalex.org/W2968485447","https://openalex.org/W2970354942","https://openalex.org/W3093335081"],"related_works":["https://openalex.org/W4317773660","https://openalex.org/W3092609933","https://openalex.org/W4311697950","https://openalex.org/W4317928308","https://openalex.org/W3091971999","https://openalex.org/W4221030343","https://openalex.org/W4387980754","https://openalex.org/W3126998810","https://openalex.org/W2752584372","https://openalex.org/W4389429670"],"abstract_inverted_index":{"BACKGROUND:":[0],"Tezepelumab":[1],"is":[2,46,56,195,220],"a":[3,47,57,264],"human":[4],"monoclonal":[5],"antibody":[6],"that":[7],"blocks":[8],"the":[9,12,107,180,198,210,223,270,285,307,321],"activity":[10],"of":[11,25,51,187,203,209,213,226,251,261,273,291,310,325],"epithelial":[13],"cytokine":[14],"thymic":[15],"stromal":[16],"lymphopoietin.":[17],"The":[18,99,192,217],"efficacy,":[19],"safety":[20,200,323],"and":[21,41,68,109,112,175,201,289,328],"oral":[22,97],"corticosteroid-sparing":[23],"potential":[24,332],"tezepelumab":[26,122,157,204,227,252,274,292,311,327],"are":[27,78],"being":[28],"investigated":[29],"in":[30,63,129,336],"two":[31],"ongoing,":[32],"phase":[33],"3,":[34],"randomized,":[35,58],"double-blind,":[36,59],"placebo-controlled":[37,60],"studies":[38],"(NAVIGATOR":[39],"[NCT03347279]":[40],"SOURCE":[42,113,234],"[NCT03406078]).":[43],"DESTINATION":[44,55,174,282,303],"(NCT03706079)":[45],"long-term":[48,199,224,286,322,333],"extension":[49],"(LTE)":[50],"these":[52,188],"studies.":[53],"METHODS:":[54],"LTE":[61,316],"study":[62,100,132,176,317],"adults":[64],"(18-80":[65],"years":[66,71],"old)":[67,72],"adolescents":[69],"(12-17":[70],"with":[73,81,94,295,338],"severe,":[74,339],"uncontrolled":[75,340],"asthma":[76,229],"who":[77,105,117,143,247],"receiving":[79,326],"treatment":[80,211,253,276,313,334],"medium-":[82],"or":[83,95,161,184,263],"high-dose":[84],"inhaled":[85],"corticosteroids":[86],"plus":[87],"at":[88],"least":[89],"one":[90],"additional":[91],"controller":[92,171],"medication":[93],"without":[96],"corticosteroids.":[98],"population":[101],"will":[102,133,150,167,178,235,254,278,283,304],"comprise":[103],"patients":[104,337],"complete":[106,248],"52-":[108],"48-week":[110],"NAVIGATOR":[111,246],"studies,":[114],"respectively.":[115],"Patients":[116,166,231,243],"were":[118,144],"randomized":[119,146],"to":[120,135,147,154,182,196,221,300,319,329],"receive":[121,136,148,155,168],"210":[123,158],"mg":[124,159],"every":[125],"4":[126],"weeks":[127,207,250,260],"(Q4W)":[128],"either":[130,156,214,258],"predecessor":[131,215],"continue":[134],"this":[137],"regimen":[138],"for":[139,163,240,257,298],"1":[140,164],"year;":[141],"those":[142],"previously":[145],"placebo":[149,162,294],"be":[151,236,255,279],"re-randomized":[152],"(1:1)":[153],"Q4W":[160],"year.":[165],"their":[169],"prescribed":[170],"medications":[172],"throughout":[173],"physicians":[177],"have":[179],"opportunity":[181],"down-":[183],"up-titrate":[185],"dosage":[186],"medications,":[189],"if":[190],"appropriate.":[191],"primary":[193],"objective":[194,219],"evaluate":[197,284,306],"tolerability":[202,288],"over":[205],"104":[206],"(inclusive":[208],"period":[212],"study).":[216],"secondary":[218],"assess":[222,330],"effect":[225,309],"on":[228],"exacerbations.":[230],"recruited":[232,244],"from":[233,245],"followed":[237],"up":[238,299],"post-treatment":[239],"12":[241,259],"weeks.":[242],"100":[249],"eligible":[256],"follow-up":[262,267],"36-week":[265],"extended":[266],"during":[268],"which":[269],"clinical":[271,308],"benefit":[272],"after":[275,312],"cessation":[277],"investigated.":[280],"DISCUSSION:":[281],"safety,":[287],"efficacy":[290],"versus":[293],"continued":[296],"dosing":[297],"2":[301],"years.":[302],"also":[305],"cessation.":[314],"This":[315],"aims":[318],"elucidate":[320],"implications":[324],"its":[331],"benefits":[335],"asthma.":[341],"TRIAL":[342],"REGISTRATION:":[343],"NCT03706079":[344],"(ClinicalTrials.gov).":[345],"Registered":[346],"15":[347],"October":[348],"2018.":[349]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3094053938","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":16},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":20},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2020-10-29T00:00:00"}
